NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 25,450
+1,350 (5.60%)
Aug 11, 2026, 3:30 PM KST
NeoPharm CO., LTD. Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 132,184 | 132,184 | 119,014 | 97,105 | 85,033 | 87,931 |
Revenue Growth | 11.07% | 11.07% | 22.56% | 14.20% | -3.29% | 7.72% |
Gross Profit Gross Profit Growth | 86,398 | 86,398 | 74,027 | 65,385 | 58,380 | 62,386 |
Operating Income Operating Income Growth | 28,775 | 28,775 | 24,653 | 25,307 | 21,439 | 22,431 |
Net Income Net Income Growth | 27,823 | 27,823 | 23,065 | 23,213 | 17,027 | 17,713 |
Earnings Per Share EPS Growth | 1778.81 | 1778.81 | 1474.61 | 1484.00 | 1088.50 | 1132.47 |
EPS Growth | 20.63% | 20.63% | -0.63% | 36.33% | -3.88% | -1.35% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 108,121 | 108,121 | 101,930 | 82,997 | 74,744 | 79,138 |
Europe Europe Growth | 8,958 | 8,958 | 7,343 | 4,852 | - | - |
Asia Asia Growth | 13,455 | 13,455 | 8,341 | 8,773 | - | - |
North America North America Growth | 1,650 | 1,650 | 1,400 | 482.84 | - | - |
Total Total Growth | 132,184 | 132,184 | 119,014 | 97,105 | 85,033 | 87,931 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 141,739 | 141,739 | 126,524 | 111,990 | 113,485 | 105,049 |
Total Debt Total Debt Growth | 1,915 | 1,915 | 629.4 | 1,065 | 412.16 | 558.77 |
Net Cash (Debt) Net Cash Growth | 139,824 | 139,824 | 125,895 | 110,925 | 113,073 | 104,490 |
Net Cash Growth | 11.06% | 11.06% | 13.50% | -1.90% | 8.21% | 13.74% |
Net Cash Per Share Net Cash Per Share Growth | 8939.41 | 8939.41 | 8048.91 | 7091.80 | 7229.16 | 6680.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 28,410 | 28,410 | 18,631 | 23,263 | 18,161 | 21,681 |
Capital Expenditures CapEx Growth | -1,185 | -1,185 | -2,799 | -19,852 | -454 | -320.11 |
Free Cash Flow Free Cash Flow Growth | 27,225 | 27,225 | 15,832 | 3,411 | 17,707 | 21,361 |
Free Cash Flow Growth | 71.97% | 71.97% | 364.17% | -80.74% | -17.11% | 27.24% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 65.36% | 65.36% | 62.20% | 67.33% | 68.66% | 70.95% |
Operating Margin | 21.77% | 21.77% | 20.71% | 26.06% | 25.21% | 25.51% |
Pretax Margin | 24.41% | 24.41% | 25.38% | 30.25% | 27.43% | 27.11% |
Profit Margin | 21.05% | 21.05% | 19.38% | 23.91% | 20.02% | 20.14% |
FCF Margin | 20.60% | 20.60% | 13.30% | 3.51% | 20.82% | 24.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 750.000 | 750.000 | 600.000 | 375.000 | 350.000 | 350.000 |
Dividend Per Share Growth | 25.00% | 25.00% | 60.00% | 7.14% | 0% | 7.69% |
Dividend Yield | 3.55% | 4.08% | 5.27% | 3.17% | 4.11% | 3.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.55 | 10.33 | 7.84 | 8.71 | 8.82 | 10.95 |
Forward PE | 11.76 | 10.94 | 7.02 | 8.05 | 8.05 | 10.43 |
P/FCF Ratio | 13.85 | 10.55 | 11.42 | 59.27 | 8.48 | 9.08 |
PS Ratio | 2.85 | 2.17 | 1.52 | 2.08 | 1.77 | 2.21 |